Literature DB >> 17388995

Cognitive and behavioural predictors of progression rates in Alzheimer's disease.

I Buccione1, R Perri, G A Carlesimo, L Fadda, L Serra, S Scalmana, C Caltagirone.   

Abstract

Cognitive and functional decline in Alzheimer's disease (AD) may show different, yet correlated, rates of progression. Over a 2-year period we investigated the predictive role of neuropsychological and behavioural variables on the cognitive and functional decline of 43 patients with AD. Slow and fast decliners were defined on the basis of cognitive and functional indexes of disease progression. We found that cognitive decline was predicted by diffuse cognitive impairment and functional progression by visuospatial deficits. Psychotic symptoms predicted faster disease progression in both cognitive and functional dimensions.

Entities:  

Mesh：

Year:  2007        PMID： 17388995     DOI： 10.1111/j.1468-1331.2007.01693.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


  20 in total

1.  Rapid cognitive decline in Alzheimer's disease. Consensus paper.

Authors:  M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

2.  Visuoconstructional Impairment in Subtypes of Mild Cognitive Impairment.

Authors:  Samrah Ahmed; Laura Brennan; Joel Eppig; Catherine C Price; Melissa Lamar; Lisa Delano-Wood; Katherine J Bangen; Emily C Edmonds; Lindsey Clark; Daniel A Nation; Amy Jak; Rhoda Au; Rodney Swenson; Mark W Bondi; David J Libon
Journal:  Appl Neuropsychol Adult       Date:  2015-09-23       Impact factor: 2.248

3.  The Multiple Features Target Cancellation (MFTC): an attentional visual conjunction search test. Normative values for the Italian population.

Authors:  C Marra; G Gainotti; E Scaricamazza; C Piccininni; M Ferraccioli; D Quaranta
Journal:  Neurol Sci       Date:  2012-02-19       Impact factor: 3.307

4.  Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/aggression.

Authors:  Laura B Zahodne; Katherine Ornstein; Stephanie Cosentino; D P Devanand; Yaakov Stern
Journal:  Am J Geriatr Psychiatry       Date:  2013-07-17       Impact factor: 4.105

5.  Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.

Authors:  Lauren P Wadsworth; Natacha Lorius; Nancy J Donovan; Joseph J Locascio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  Dement Geriatr Cogn Disord       Date:  2012-08-28       Impact factor: 2.959

6.  Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities.

Authors:  Giuseppe Tosto; Molly E Zimmerman; Owen T Carmichael; Adam M Brickman
Journal:  JAMA Neurol       Date:  2014-07-01       Impact factor: 18.302

7.  Less efficient pattern separation may contribute to age-related spatial memory deficits.

Authors:  Heather M Holden; Paul E Gilbert
Journal:  Front Aging Neurosci       Date:  2012-05-29       Impact factor: 5.750

8.  Predictors of the progression of dementia severity in brazilian patients with Alzheimer's disease and vascular dementia.

Authors:  Márcia L Chaves; Ana L Camozzato; Cristiano Köhler; Jeffrey Kaye
Journal:  Int J Alzheimers Dis       Date:  2010-03-14

9.  Balance and Mobility as Predictors of Post-Stroke Cognitive Impairment.

Authors:  Marie Helene Ursin; Astrid Bergland; Brynjar Fure; Audhild Tørstad; Arnljot Tveit; Hege Ihle-Hansen
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-05-29

10.  Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors.

Authors:  Massimo Musicco; Katie Palmer; Giovanna Salamone; Federica Lupo; Roberta Perri; Serena Mosti; Gianfranco Spalletta; Fulvia di Iulio; Carla Pettenati; Luca Cravello; Carlo Caltagirone
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.